Global Liquid Biopsy Market Research and Forecast Report 2022-2027
© 2019 IMARC All Rights Reserved
Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group
Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Report Description and Highlights Report Description Global Liquid Biopsy Market Research Report: According to the latest report by IMARC Group, titled “ Liquid Biopsy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-20 27 ,” the global liquid biopsy market reached a strong growth in 2021. Liquid biopsy is the non-invasive sampling and analysis of liquid state biological tissue, enabling doctors to obtain information about diseases like cancer and tumors. This technique can reflect the changes in gene expression profile and provide a robust base for individualized therapy. It is used for monitoring and diagnosing diseases through advanced procedures like human genome sequencing. Liquid biopsy is a fast, convenient and reproducible sampling method that facilitates the early screening of cancer, monitors progression, accesses therapeutic response and clinical prognosis, and detects recurrent and refractory tumors. Request Free Sample Report: https://www.imarcgroup.com/liquid-biopsy-market/requestsample
Report Description and Highlights Report Description Global Liquid Biopsy Market Trends : Liquid biopsy reduces the apprehension of patients regarding pain and provides a safe and effective method of diagnosis. As a result, there has been increasing demand for a non-invasive alternative, such as liquid biopsy, over tissue biopsy that involves the painful extraction of diseased tissue, which is fueling the market growth. In addition, the rising prevalence of cancer due to environmental factors, tobacco consumption, Hepatitis B and C, and lifestyle changes is also escalating the demand for liquid biopsy. Besides this, liquid biopsy is also widely adopted as this technique detects epidermal growth factor receptor (EGFR) gene mutation among patients with non-small cell lung cancer (NSCLC). Furthermore, technological advancements and extensive investments in research and development (R&D) activities to encourage the introduction of advanced cancer solutions are anticipated to positively influence the market growth in the upcoming years. Looking forward, the market value is projected to reach a strong growth during the forecast period (2022-2027).
Report Description and Highlights Report Description Market Summary: Breakup by Product and Service: • Kits and Reagents • Platforms and Instruments • Services Breakup by Circulating Biomarker: • Circulating Tumor Cells • Extracellular Vesicles • Circulating Tumor DNA • Others
Report Description and Highlights Report Description Breakup by Cancer Type: • Lung Cancer • Breast Cancer • Colorectal Cancer • Prostate Cancer • Liver Cancer • Others Breakup by End User: • Hospitals and Laboratories • Academic and Research Centers • Others
Report Description and Highlights Report Description Breakup by Region: •North America • United States • Canada •Asia Pacific • China • Japan • India • South Korea • Australia • Indonesia • Others •Europe • Germany • France • United Kingdom • Italy • Spain • Russia • Others
Report Description and Highlights Report Description •Latin America • Brazil • Mexico • Others •Middle East and Africa Note: We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report.
Report Description and Highlights Report Description Competitive Landscape with Key Players: • • • • • • • • • • • •
ANGLE plc Biocept Inc. Bio-Rad Laboratories Inc Epigenomics AG Exact Sciences Corporation F. Hoffmann-La Roche AG Guardant Health Inc. Illumina Inc. MDxHealth SA Menarini Silicon Biosystems QIAGEN N.V. Thermo Fisher Scientific Inc
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/liquid-biopsy-market
A partial List of
We are the trusted business partners to the
Clients world's leading corporates, governments, and ourPartial ClientsList of institutions
We are the trusted business partners to the Partial Listworld's of Clients leading corporates, governments, and institutions
A partial List of our Clients
Report Description and Highlights
Report Description
© 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
Contact Us
FOR MORE DETAILS Visit us at :
https://www.imarcgroup.com Stay With Us:
TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com